Close
  • Latest News
  • Cybersecurity
  • Big Data and Analytics
  • Cloud
  • Mobile
  • Networking
  • Storage
  • Applications
  • IT Management
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Menu
Search
  • Latest News
  • Cybersecurity
  • Big Data and Analytics
  • Cloud
  • Mobile
  • Networking
  • Storage
  • Applications
  • IT Management
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Home IT Management
    • IT Management

    Google Seeks Patent for Needle-Less Blood-Draw Tech

    By
    Jaikumar Vijayan
    -
    December 7, 2015
    Share
    Facebook
    Twitter
    Linkedin
      Google health care

      Google is seeking to patent a technology that would enable the needle-less drawing of blood for the medical testing of patients with diabetes and other health conditions.

      The company’s patent application, published Dec. 3, described the technology as a pneumatic particle accelerator designed to shoot a micro particle through a small, hollow tube with enough velocity to “imperceptibly” break the skin and draw a minute amount of blood for testing.

      The device will apparently be small enough to be integrated into a wristband or a smartwatch. It could also work as a handheld device of about the size of a pencil or a typical hypodermic needle-carrying barrel.

      According to Google, the technology offers a way to extract blood without any of the discomfort associated with puncturing the skin with a needle or a lancet. “Generally, the smaller the puncture, the smaller the degree of discomfort that may accompany a blood draw,” Google’s patent application noted.

      While needles and lancets used for blood draw purposes have become smaller in diameter and thus less uncomfortable to use, they can only get so small before they become impractical, Google said. The patent application covers a device and technique for the “medical extraction of blood that can imperceptibly pierce dermal tissue without a piercing element,” the company said.

      The Stack was the first to report on Google’s patent application.

      The technology described in the application could be years away from commercialization. Even so, it highlights the growing investments that the company has begun making in the health care space, an area that some think holds huge revenue potential for Google.

      When Google announced its business reorganization earlier this year, its Life Science’s group, which is where most of its health initiatives are, was one of the first businesses to be carved out as a separate company under the Alphabet umbrella.

      The group is involved in several major health-related projects, most notably those involving the treatment and care of people with diabetes. One example is its effort with Swiss pharmaceutical giant Novartis to develop a smart contact lens technology that would be capable of detecting blood sugar levels in diabetes patients from their tears. The first human tests of the smart contact lens are expected to begin in 2016.

      Similarly, Google earlier this year said it would work with French firm Sanofi to find new ways of managing diabetes. As part of the collaboration, Google is working on applying its expertise in the area of big data analytics to study massive volumes of data related to diabetes care and treatment. The company is also working with DexCom of San Diego to build small, low-cost, disposable continuous glucose level monitoring tools for diabetes patients.

      Google’s health-related projects extend to areas well beyond diabetes management. The company has a partnership with Johnson & Johnson subsidiary Ethicon to develop minimally invasive surgical instruments. It has a similar arrangement with Lift Labs to develop smart spoon technology for people with hand tremors caused by diseases like Parkinson’s and other neurological disorders.

      In addition to these initiatives, Google also has invested in Calico, a life sciences company led by a former chief executive of biotech firm Genentech and other senior executives from the firm. Last year, Calico and AbbVie announced they would co-invest up to $1.5 billion in a research and development facility focused on age-related diseases and cancer.

      Avatar
      Jaikumar Vijayan
      Vijayan is an award-winning independent journalist and tech content creation specialist covering data security and privacy, business intelligence, big data and data analytics.

      MOST POPULAR ARTICLES

      Android

      Samsung Galaxy XCover Pro: Durability for Tough...

      Chris Preimesberger - December 5, 2020 0
      Have you ever dropped your phone, winced and felt the pain as it hit the sidewalk? Either the screen splintered like a windshield being...
      Read more
      Cloud

      Why Data Security Will Face Even Harsher...

      Chris Preimesberger - December 1, 2020 0
      Who would know more about details of the hacking process than an actual former career hacker? And who wants to understand all they can...
      Read more
      Cybersecurity

      How Veritas Is Shining a Light Into...

      eWEEK EDITORS - September 25, 2020 0
      Protecting data has always been one of the most important tasks in all of IT, yet as more companies become data companies at the...
      Read more
      Big Data and Analytics

      How NVIDIA A100 Station Brings Data Center...

      Zeus Kerravala - November 18, 2020 0
      There’s little debate that graphics processor unit manufacturer NVIDIA is the de facto standard when it comes to providing silicon to power machine learning...
      Read more
      Apple

      Why iPhone 12 Pro Makes Sense for...

      Wayne Rash - November 26, 2020 0
      If you’ve been watching the Apple commercials for the past three weeks, you already know what the company thinks will happen if you buy...
      Read more
      eWeek


      Contact Us | About | Sitemap

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Property of TechnologyAdvice.
      Terms of Service | Privacy Notice | Advertise | California - Do Not Sell My Information

      © 2021 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.

      ×